Cargando…

Evaluation of Risk-Based Approaches to the Registration of Medicines: Current Status Among African Regulatory Authorities

BACKGROUND: Despite the worldwide need for increased access to safe and effective medicines, there is a lack of innovative medicines in many low- to middle-income countries. On the African continent, this is partly due to capacity limitations of National Regulatory Authorities (NRAs). One important...

Descripción completa

Detalles Bibliográficos
Autores principales: McAuslane, Neil, Bujar, Magda, Sithole, Tariro, Ngum, Nancy, Owusu-Asante, Mercy, Walker, Stuart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113993/
https://www.ncbi.nlm.nih.gov/pubmed/37074548
http://dx.doi.org/10.1007/s40290-023-00472-0
_version_ 1785027937531068416
author McAuslane, Neil
Bujar, Magda
Sithole, Tariro
Ngum, Nancy
Owusu-Asante, Mercy
Walker, Stuart
author_facet McAuslane, Neil
Bujar, Magda
Sithole, Tariro
Ngum, Nancy
Owusu-Asante, Mercy
Walker, Stuart
author_sort McAuslane, Neil
collection PubMed
description BACKGROUND: Despite the worldwide need for increased access to safe and effective medicines, there is a lack of innovative medicines in many low- to middle-income countries. On the African continent, this is partly due to capacity limitations of National Regulatory Authorities (NRAs). One important approach to address this issue is work sharing and regulatory reliance. Therefore, the aim of this study of regulatory authorities on the African continent was to identify which risk-based approaches are being used as well as their foreseen role in the future. METHODS: The study employed a questionnaire to identify which risk-based models are used for the regulatory approval of medicines and to determine which frameworks are in place to enable a risk-based approach, as well as to provide insight into the future direction for risk-based models. The questionnaire was sent electronically to 26 NRAs in the African Continent. RESULTS: Twenty-one authorities (80%) completed the questionnaire. Work sharing was the most commonly used model, followed closely by unilaterial reliance, information sharing, and collaborative review. These methods were perceived to be an effective and efficient use of resources, enabling faster medicine availability for patients. The unilateral reliance approach by the authorities included abridged (85%), verification (70%) and recognition (50%) models for a range of products. However, challenges included a lack of guidelines to undertake a reliance review together with resource constraints, while access to assessment reports was the most common barrier to using a unilateral reliance model. CONCLUSIONS: Many authorities in Africa have adopted a risk-based approach to medicines registration and created work sharing, unilateral reliance pathways and regionalisation models to facilitate the availability of medicines. The authorities believe that in future, assessment routes should move from stand-alone reviews to risk-based models. However, this study indicated that there would be challenges to implement this approach in practice, which would include improving resource capacity and the number of expert reviewers as well as implementing electronic tracking systems. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40290-023-00472-0.
format Online
Article
Text
id pubmed-10113993
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-101139932023-04-20 Evaluation of Risk-Based Approaches to the Registration of Medicines: Current Status Among African Regulatory Authorities McAuslane, Neil Bujar, Magda Sithole, Tariro Ngum, Nancy Owusu-Asante, Mercy Walker, Stuart Pharmaceut Med Original Research Article BACKGROUND: Despite the worldwide need for increased access to safe and effective medicines, there is a lack of innovative medicines in many low- to middle-income countries. On the African continent, this is partly due to capacity limitations of National Regulatory Authorities (NRAs). One important approach to address this issue is work sharing and regulatory reliance. Therefore, the aim of this study of regulatory authorities on the African continent was to identify which risk-based approaches are being used as well as their foreseen role in the future. METHODS: The study employed a questionnaire to identify which risk-based models are used for the regulatory approval of medicines and to determine which frameworks are in place to enable a risk-based approach, as well as to provide insight into the future direction for risk-based models. The questionnaire was sent electronically to 26 NRAs in the African Continent. RESULTS: Twenty-one authorities (80%) completed the questionnaire. Work sharing was the most commonly used model, followed closely by unilaterial reliance, information sharing, and collaborative review. These methods were perceived to be an effective and efficient use of resources, enabling faster medicine availability for patients. The unilateral reliance approach by the authorities included abridged (85%), verification (70%) and recognition (50%) models for a range of products. However, challenges included a lack of guidelines to undertake a reliance review together with resource constraints, while access to assessment reports was the most common barrier to using a unilateral reliance model. CONCLUSIONS: Many authorities in Africa have adopted a risk-based approach to medicines registration and created work sharing, unilateral reliance pathways and regionalisation models to facilitate the availability of medicines. The authorities believe that in future, assessment routes should move from stand-alone reviews to risk-based models. However, this study indicated that there would be challenges to implement this approach in practice, which would include improving resource capacity and the number of expert reviewers as well as implementing electronic tracking systems. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40290-023-00472-0. Springer International Publishing 2023-04-19 2023 /pmc/articles/PMC10113993/ /pubmed/37074548 http://dx.doi.org/10.1007/s40290-023-00472-0 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Research Article
McAuslane, Neil
Bujar, Magda
Sithole, Tariro
Ngum, Nancy
Owusu-Asante, Mercy
Walker, Stuart
Evaluation of Risk-Based Approaches to the Registration of Medicines: Current Status Among African Regulatory Authorities
title Evaluation of Risk-Based Approaches to the Registration of Medicines: Current Status Among African Regulatory Authorities
title_full Evaluation of Risk-Based Approaches to the Registration of Medicines: Current Status Among African Regulatory Authorities
title_fullStr Evaluation of Risk-Based Approaches to the Registration of Medicines: Current Status Among African Regulatory Authorities
title_full_unstemmed Evaluation of Risk-Based Approaches to the Registration of Medicines: Current Status Among African Regulatory Authorities
title_short Evaluation of Risk-Based Approaches to the Registration of Medicines: Current Status Among African Regulatory Authorities
title_sort evaluation of risk-based approaches to the registration of medicines: current status among african regulatory authorities
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113993/
https://www.ncbi.nlm.nih.gov/pubmed/37074548
http://dx.doi.org/10.1007/s40290-023-00472-0
work_keys_str_mv AT mcauslaneneil evaluationofriskbasedapproachestotheregistrationofmedicinescurrentstatusamongafricanregulatoryauthorities
AT bujarmagda evaluationofriskbasedapproachestotheregistrationofmedicinescurrentstatusamongafricanregulatoryauthorities
AT sitholetariro evaluationofriskbasedapproachestotheregistrationofmedicinescurrentstatusamongafricanregulatoryauthorities
AT ngumnancy evaluationofriskbasedapproachestotheregistrationofmedicinescurrentstatusamongafricanregulatoryauthorities
AT owusuasantemercy evaluationofriskbasedapproachestotheregistrationofmedicinescurrentstatusamongafricanregulatoryauthorities
AT walkerstuart evaluationofriskbasedapproachestotheregistrationofmedicinescurrentstatusamongafricanregulatoryauthorities